The global cardiovascular repair and reconstruction devices market size is expected to reach USD 5.20 billion by 2030 and expand at a CAGR of 5.8% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increase in the prevalence of Congenital Heart Defects (CHDs) and the availability of technologically advanced cardiovascular valves, grafts, and patches are among the key factors expected to drive growth over the forecast period.
Various initiatives by government organizations for the management of cardiovascular diseases is also expected to drive growth. For instance, the American Heart Association funds research projects pertaining to CVD. It has funded some breakthrough projects in cardiology, such as techniques & standards for Cardiopulmonary Resuscitation (CPR), the first artificial heart valve, cholesterol inhibitors, implantable pacemakers, drug-eluting stents, and microsurgery. The foundation has funded more than USD 4 billion in the research projects since 1949.
Increase in the demand for effective therapies that reduce the incidence of adverse cardiac remodeling and help in regeneration or replacement of the myocardial tissues that get damaged during ischemic events is also anticipated to boost the cardiovascular repair and reconstruction devices market over the forecast period. Incidence of various CVD, such as heart attacks, stroke, and cardiac arrest, is rising owing to several risk factors such as changes in lifestyle, smoking, alcohol consumption, physical inactivity, improper nutrition, and obesity. According to the American Heart Association, cardiovascular diseases accounted for about one in three deaths in the U.S. The medical cost of CHD is anticipated to increase by nearly 100% between 2013 to 2030. These factors are expected to boost growth over the forecast period.
Technological advancements in the fields of material sciences, interventional cardiology, and cryopreservation are also expected to drive the cardiovascular reconstruction devices market. The use of expanded PTFE for cardiovascular patches, the introduction of transcatheter heart valves, and the development of minimally invasive technologies, such as transcatheter aortic valve implantation or transcatheter aortic valve replacement, are among few factors expected to boost growth over the forecast period. In addition, developments in cryopreservation techniques by key players such as CryoLife are among major technological advancements in cardiovascular therapies that are predicted to positively influence the market.
Request a free sample copy or view report summary: Cardiovascular Repair And Reconstruction Devices Market Report
Vascular graft products dominated the market with a revenue share of 71.3% in 2023. This dominance is linked to the rising demand for less invasive procedures, which is driven by developments in clinical pharmacology, cell biology, vascular surgery, and molecular chemistry.
The valve repair segment is expected to grow fastest at a CAGR of 6.9% from 2024 to 2030. This growth is driven by advancements in the treatment of cardiovascular conditions related to heart valves.
North America dominated the market with revenue share of 48.66% in 2023. Growing urbanization and technological advancement, rapidly growing markets, and rising disposable income are the factors attributed to the market's growth in the region.
The Asia Pacific market for cardiovascular repair and reconstruction devices is expected to experience substantial growth in the coming years. This growth can be attributed to a large population, increasing demand, a growing number of elderly individuals, and higher disposable incomes.
Grand View Research has segmented global construction repair and reconstruction devices market report based on product and region:
Cardiovascular Repair And Reconstruction Devices Product Outlook (Revenue, USD Billion, 2018 - 2030)
Heart Valve Repair
Vascular Graft
Endovascular Stent Graft
Hemodialysis Access Graft
Peripheral Vascular Graft
Cardiovascular Patches
Cardiac Repair Patches
Atrial Septal Defect
Common Atrium
Defects of the Endocardial Cushion
Ventricular Septal Defect
Tetralogy of Fallot
Suture bleeding
Vascular Repair Patches
Carotid Endarterectomy
Anomalous Connection of The Pulmonary Veins
Transposition of the Great Vessels
Reconstruction of Portal and Superior Mesenteric Veins
Other Vascular Repair Applications
Cardiovascular Repair And Reconstruction Devices Regional Outlook (Revenue, USD Billion, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
China
Japan
India
South Korea
Australia
Thailand
Latin America
Brazil
Argentina
Middle East and Africa (MEA)
KSA
UAE
South Africa
Kuwait
List of Key Players in the Cardiovascular Repair And Reconstruction Devices Market
Medtronic plc
BD
TERUMO CORPORATION
W. L. Gore & Associates, Inc.
Getinge
Artivion, Inc
Edwards Lifesciences Corporation
"The quality of research they have done for us has been excellent..."